133 related articles for article (PubMed ID: 36189536)
1. Platelet Count as a Prognostic Factor in Stage IV Non-Small Cell Lung Cancer.
Saha B; Khatun N; Azim N; Islam SA; Proteek MF; Islam MR; Begum FA; Biddut MA; Khan MK; Islam MR
Mymensingh Med J; 2022 Oct; 31(4):937-946. PubMed ID: 36189536
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.
Kim KH; Park TY; Lee JY; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Yang SC
J Korean Med Sci; 2014 Apr; 29(4):507-11. PubMed ID: 24753697
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of thrombocytosis in patients with primary lung cancer.
Pedersen LM; Milman N
Eur Respir J; 1996 Sep; 9(9):1826-30. PubMed ID: 8880098
[TBL] [Abstract][Full Text] [Related]
4. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
Ji Y; Sheng L; Du X; Qiu G; Su D
Platelets; 2015; 26(2):138-42. PubMed ID: 24679181
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Onitsuka T
Gen Thorac Cardiovasc Surg; 2010 Nov; 58(11):573-6. PubMed ID: 21069496
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of thrombocytosis in newly diagnosed lung cancer patients: a retrospective analysis.
Cakar B; Karaoglanoglu M; Sayici Y; Gonullu Demirag G; Yucel I
J BUON; 2011; 16(4):677-81. PubMed ID: 22331721
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of thrombocytosis in patients with primary lung cancer].
Pedersen LM; Milman N
Ugeskr Laeger; 1998 Jun; 160(26):3917-20. PubMed ID: 9656833
[TBL] [Abstract][Full Text] [Related]
9. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer.
Pedersen LM; Milman N
Oncol Rep; 2003; 10(1):213-6. PubMed ID: 12469171
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy.
Holgersson G; Bergstrom S; Hallqvist A; Liv P; Nilsson J; Willen L; Nyman J; Ekman S; Henriksson R; Bergqvist M
Neoplasma; 2017; 64(6):909-915. PubMed ID: 28895417
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
Suppiah R; Shaheen PE; Elson P; Misbah SA; Wood L; Motzer RJ; Negrier S; Andresen SW; Bukowski RM
Cancer; 2006 Oct; 107(8):1793-800. PubMed ID: 16983701
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the factors associated with abnormal coagulation and prognosis
in patients with non-small cell lung cancer].
Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
[TBL] [Abstract][Full Text] [Related]
15. Preoperative thrombocytosis in surgically treated patients with non-small cell lung cancer.
Skorek P; Stępień K; Fila M; Hauer J; Kużdżał J
Pol Arch Intern Med; 2018 Sep; 128(9):512-517. PubMed ID: 30057382
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):613-5. PubMed ID: 18502783
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
Inagaki N; Kibata K; Tamaki T; Shimizu T; Nomura S
Lung Cancer; 2014 Jan; 83(1):97-101. PubMed ID: 24189108
[TBL] [Abstract][Full Text] [Related]
18. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
20. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
